Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended 30 September 2023.
The above information is a part of company’s filings submitted to BSE.